Currently predicting for Thu, 4 Jun 2026

LLY Prediction Chart

LLY Predictions History

Latest community submissions for LLY.
Predictor Target Session Target Price Result Direction Accuracy Score
Dec 10, 2025 Bullish $992.94 V 1
Dec 1, 2025 $1,060.90 -1.07% $1,057.89 V 99.72% 5
Dec 1, 2025 $1,065.23 -0.67% $1,057.89 V 99.31% 4
Dec 1, 2025 Bullish $1,057.89 X 0
Nov 17, 2025 Bullish $1,021.70 X 0
Nov 13, 2025 $1,005.81 -1.18% $1,022.87 X 98.33% 0
Nov 13, 2025 $1,010.30 -0.74% $1,022.87 X 98.77% 1
Nov 13, 2025 $1,049.46 +6.15% $1,022.87 V 97.40% 1
Nov 4, 2025 $887.10 -1.05% $906.86 X 97.82% 0
Nov 4, 2025 $890.63 -0.66% $906.86 X 98.21% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LLY with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ELI LILLY AND COMPANY
Eli Lilly
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE